Last reviewed · How we verify
NCT03533777
Antegrade Versus Retrograde IV for Blood Draws
NA trial testing Peripheral intravenous catheter placement in There is no Focus on Any Specific Condition in 230 participants. Completed in 19 June 2019.
19 June 2019
Quick facts
| Lead sponsor | University of Iowa |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 230 |
| Start date | 22 June 2018 |
| Primary completion | 19 June 2019 |
| Estimated completion | 19 June 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Peripheral intravenous catheter placement
- Blood draw — full drug profile →
- Peripheral intravenous catheter
- To keep open (TKO) infusion of 0.9% normal saline — full drug profile →
Conditions studied
- There is no Focus on Any Specific Condition — all drugs for There is no Focus on Any Specific Condition →
Sponsor
University of Iowa
Who can join
Adults 18 to 90, any sex, with There is no Focus on Any Specific Condition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to compare success rates of antegrade and retrograde intravenous (IV) catheters in their ability to aspirate 20 milliliter blood sample within a 2 minute time frame, 3 hours after initial insertion. Antegrade IV catheters are placed identically to conventional IV catheters, with the end of the catheter pointed toward the direction of blood flow to the heart. Retrograde catheters are placed "backwards" with the end of the catheter pointed away from the direction of venous blood flow. The hypothesis is that retrograde IVs will have a significantly higher success rate of blood draw at the 3 hour time mark without use of a proximal tourniquet.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03533777
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Peripheral intravenous catheter placement
Trials testing the same drug.
- NCT03740607 — Virtual Reality for Alleviation of Peripheral IV Placement-Associated Discomfort · NA · unknown
Other University of Iowa trials
Trials by the same sponsor.
- NCT07224269 — Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis · EARLY_PHASE1 · not yet recruiting
- NCT07244809 — Probing the Role of Mitochondrial Oxidative Stress in Impaired Vascular Function Among Young Adults With Early Life Adve · NA · recruiting
- NCT07097961 — Paediatric Post-TB Pulmonary Rehab Study · NA · recruiting
- NCT06951594 — Robotic-Assisted Versus Manual Electrode Array Insertion · NA · recruiting
- NCT06710119 — Effect of Custom Dynamic Orthoses on Forefoot Loading · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03533777 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Iowa
- Last refreshed: 1 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03533777.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing